bpc-157 human clinical trial results The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity This doesn't mean BPC-157 is
Description
Despite theoretical fears around cancer risks due to angiogenesis, nobody has reported personal experiences linking this peptide to tumor growth or cancer
Speeds up healing for tendons, ligaments, and muscles so you bounce back quicker from injuries

Store below 25C

It also has a layer of muscle close to the surface which promotes absorption of B12

The LEADER trial 28 (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results) studied a 1.8-mg dose in more than 9,000 patients with type 2 diabetes and found the incidence of acute pancreatitis was similar between the liraglutide and placebo groups (0.4% vs 0.5%, respectively)

Miscellaneous: Feeling of swelling of entire body
